Latest Report Available at Orbis research
Orphan Drugs Market provides pin-point analysis for changing competitive
dynamics and a forward looking perspective on different factors driving or
restraining industry growth.
An
orphan disease refers to any rare disease which affects a smaller portion of
population. Most of the rare diseases are genetic and therefore chronic.
Presently, there are around 7000 rare diseases affecting approximately 5-6% of
the global population. Half of the population of orphan disease patients is
children as most of the genetic orphan diseases occur at birth or childhood.
Generally,
orphan diseases are considered to be severe, progressive, degenerative,
life-threatening or chronically debilitating diseases which can be caused
genetically, infectiously or toxically. Despite knowing the causes of orphan
diseases, most of these diseases are still non-curable or lack satisfactory
treatments. Majority of the genetic orphan diseases are caused by defects in a
single gene due to multiple mutations.
Orphan
drug market is likely to witness a growth in future with the increasing
development and approvals of ultra-rare drugs and rising developments in drugs
for rare blood disease. The U.S. and Europe are the major contributors to the
global orphan drugs market supported by increased numbers of orphan
designations. Asia is likely to experience further growth with increasing drug approvals
in Japan and improving healthcare facilities.
The
global orphan drugs market is expected to grow in future due to prolonged
orphan drug market exclusivity, increasing sales of prescription drugs,
attractive orphan drug policies, rising healthcare expenditure, improving
economies and increasing prevalence of chronic diseases. Key trends of this
market include progressing drug pipeline, rising treatment options in oncology
and rising scope in gene therapy. However, there are some factors which can hinder
growth of the market including high costs of drugs, increased competition from
generic industry, insufficient disease information & research participants
and deficiency of diagnostic systems and trained professionals.
The
report “Global Orphan Drugs Market: Industry Analysis & Outlook
(2017-2021)” by Koncept Analytics provides an extensive research and detailed
analysis of the present market along with future outlook. The report discusses
the major growth drivers and challenges of the market, covering the U.S, Europe
and Asia along with the global market. The report profiles key players of the
market including Roche, Novartis, Bristol-Myers Squibb and Celgene.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-orphan-drugs-market-industry-analysis-and-outlook-2017-2021 .
Some points from TOC:
1. Overview
1.1 Orphan Disease
1.1 Orphan Disease
1.2 Orphan Drugs
2. Global Orphan Drugs Market
2.1 Orphan Drugs Market Value
2.2 Orphan Drugs Market Forecast by Value
2.3 Orphan Drugs Market by Product
2.4 Orphan Drugs Share in Prescription Drugs Market
2.5 Orphan Drugs Share Forecast in Prescription Drugs Market
2.1 Orphan Drugs Market Value
2.2 Orphan Drugs Market Forecast by Value
2.3 Orphan Drugs Market by Product
2.4 Orphan Drugs Share in Prescription Drugs Market
2.5 Orphan Drugs Share Forecast in Prescription Drugs Market
Purchase a copy of Orphan Drugs Market visit @ http://www.orbisresearch.com/contact/purchase/333707 For more information contact sales@orbisresearch.com .
3. Regional Markets
3.1 The Americas
3.1.1 The U.S Orphan Drugs Spending Forecast
3.1.2 The U.S. Orphan Drug Volume
3.1.3 The U.S. Orphan Drug Average & Median Cost per Patient
3.1.4 The U.S. Orphan Drug Average & Median Cost per Patient Forecast
3.1.5 Canada Orphan Drugs Spending
3.1.6 Canada Orphan Drugs Spending Forecast
3.2 Europe
3.2.1 Europe Orphan Drugs Market Forecast by Value
3.2.2 Europe Orphan Drugs Market by Product
3.2.3 Europe Orphan Drug Volume
3.3 Asia
3.3.1 Japan Orphan Drug Volume
3.3.2 India Orphan Drugs Market Value Forecast
3.1 The Americas
3.1.1 The U.S Orphan Drugs Spending Forecast
3.1.2 The U.S. Orphan Drug Volume
3.1.3 The U.S. Orphan Drug Average & Median Cost per Patient
3.1.4 The U.S. Orphan Drug Average & Median Cost per Patient Forecast
3.1.5 Canada Orphan Drugs Spending
3.1.6 Canada Orphan Drugs Spending Forecast
3.2 Europe
3.2.1 Europe Orphan Drugs Market Forecast by Value
3.2.2 Europe Orphan Drugs Market by Product
3.2.3 Europe Orphan Drug Volume
3.3 Asia
3.3.1 Japan Orphan Drug Volume
3.3.2 India Orphan Drugs Market Value Forecast
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Prolonged Orphan Drug Market Exclusivity
4.1.2 Increasing Sales of Prescription Drugs
4.1.3 Attractive Orphan Drug Policies
4.1.4 Rising Healthcare Expenditure
4.1.5 Improving Economic Condition
4.1.6 Increasing Prevalence of Chronic Diseases
4.2 Key Trends
4.2.1 Progressing Drug Pipeline
4.2.2 Increasing Treatment Options in Oncology
4.2.3 Increasing Scope of Gene Therapy
4.3 Challenges
4.3.1 High Cost Drugs
4.3.2 Lack of Diagnostic Systems and Trained Professionals
4.3.3 Insufficient Disease Information and Research Participants
4.3.4 Rising Competition from Generic Industry
4.1 Growth Drivers
4.1.1 Prolonged Orphan Drug Market Exclusivity
4.1.2 Increasing Sales of Prescription Drugs
4.1.3 Attractive Orphan Drug Policies
4.1.4 Rising Healthcare Expenditure
4.1.5 Improving Economic Condition
4.1.6 Increasing Prevalence of Chronic Diseases
4.2 Key Trends
4.2.1 Progressing Drug Pipeline
4.2.2 Increasing Treatment Options in Oncology
4.2.3 Increasing Scope of Gene Therapy
4.3 Challenges
4.3.1 High Cost Drugs
4.3.2 Lack of Diagnostic Systems and Trained Professionals
4.3.3 Insufficient Disease Information and Research Participants
4.3.4 Rising Competition from Generic Industry
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter:
https://twitter.com/orbisresearch
Like us on Facebook:
https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment